title: Precision Medicine Requires Precision Laboratories.
abstract: This commentary highlights the validation study by Lih et al that supports the use of precision medicine for improved clinical trials.
authors.affiliation: Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia.
authors.forename: Mangalathu S
authors.initials: MS
authors.lastname: Rajeevan
authors.affiliation: Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia.
authors.forename: Tengguo
authors.initials: T
authors.lastname: Li
authors.affiliation: Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia. Electronic address: eunger@cdc.gov.
authors.forename: Elizabeth R
authors.initials: ER
authors.lastname: Unger
mesh_terms: D002986:Clinical Trials as Topic; D056726:Genetic Association Studies; D059014:High-Throughput Nucleotide Sequencing / Q000379:methods / Q000592:standards; D006801:Humans; D007753:Laboratories / Q000592:standards*; D025202:Molecular Diagnostic Techniques / Q000379:methods / Q000592:standards; D058990:Molecular Targeted Therapy; D009369:Neoplasms / Q000175:diagnosis / Q000235:genetics / Q000628:therapy; D057285:Precision Medicine / Q000379:methods / Q000592:standards; D015203:Reproducibility of Results